Artivion, Inc.AORTNYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank69
5Y CAGR-1.9%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-1.9%/yr
Long-term compound
Percentile
P69
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 12.92% |
| Q3 2025 | 14.37% |
| Q2 2025 | 4.98% |
| Q1 2025 | -9.13% |
| Q4 2024 | 12.10% |
| Q3 2024 | -11.90% |
| Q2 2024 | 7.93% |
| Q1 2024 | -9.14% |
| Q4 2023 | 19.06% |
| Q3 2023 | -13.44% |
| Q2 2023 | 2.70% |
| Q1 2023 | -13.02% |
| Q4 2022 | -29.62% |
| Q3 2022 | 36.44% |
| Q2 2022 | -14.61% |
| Q1 2022 | 7.06% |
| Q4 2021 | -5.13% |
| Q3 2021 | 19.28% |
| Q2 2021 | 7.82% |
| Q1 2021 | 17.95% |
| Q4 2020 | 14.23% |
| Q3 2020 | 4.22% |
| Q2 2020 | -13.12% |
| Q1 2020 | 19.65% |
| Q4 2019 | -15.13% |
| Q3 2019 | 7.16% |
| Q2 2019 | 5.28% |
| Q1 2019 | -18.22% |
| Q4 2018 | 29.84% |
| Q3 2018 | -8.64% |
| Q2 2018 | 6.50% |
| Q1 2018 | -15.61% |
| Q4 2017 | 48.77% |
| Q3 2017 | -9.54% |
| Q2 2017 | 15.51% |
| Q1 2017 | 6.48% |
| Q4 2016 | 3.50% |
| Q3 2016 | 13.27% |
| Q2 2016 | 25.68% |
| Q1 2016 | 2.72% |